Avac Event

Making AIDS History: A Roadmap for Ending the Epidemic


Where: Senate Hart Office Building – Room 902
When: Noon − 5pm
Additional details: Lunch will be served

To RSVP, click here.

For information, contact [email protected] or 571-286-5950.

Topics will include HIV/AIDS and the opioid epidemic, aging with HIV/AIDS, the national security implications of epidemics, and the need for cutting-edge research and services to end the HIV/AIDS epidemic.

Speakers include:

  • Ambassador Deborah Birx
    Global AIDS Coordinator, US Department of State
  • Susan J. Blumenthal, MD, MPA
    Senior Policy and Medical Advisor, amfAR
    Former US Assistant Surgeon General
  • Michael Botticelli
    Director, Grayken Center for Addiction Medicine, Boston University Medical Center
    Former Director, White House Office of National Drug Control Policy
  • Kenneth Cole
    Chairman of the Board, amfAR
  • Tony Fauci, MD
    Director, National Institute of Allergy and Infectious Diseases, NIH
  • Maureen Goodenow, PhD
    Director, Office of AIDS Research, National Institutes of Health
  • Ron Klain
    Former White House Ebola Response Coordinator
    Executive Vice President, Revolution
  • Holly Kuzmich
    Executive Director, The Bush Institute
  • Jonathan Mermin, MD, MPH
    Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
    Centers for Disease Control and Prevention (CDC)
  • Michel Sidibé
    Executive Director, UNAIDS
    Under-Secretary-General, United Nations
  • Judy Woodruff, Moderator
    Anchor and Managing Editor, PBS Newshour

Avac Event

Webinar: “Plan B”-NAb? An Overview of Antibody Research with Lynn Morris

Dr. Lynn Morris, head of HIV Virology at South Africa’s National Institute for Communicable Diseases and professor at the University of the Witwatersrand in Johannesburg, provided an overview of antibody research for HIV prevention. She laid out the current landscape; provided a glimpse of what is to come in this dynamic field; talked about where antibody work fits in the larger field of prevention research; and described how the Antibody Mediated Prevention (AMP) studies – ongoing proof-of-concept trials of the broadly neutralizing antibody VRC01 – might advance HIV prevention.

This was the fourth in our series of HIV Vaccine Awareness Day webinars. For details on the full series, visit avac.org/hvad.

Recording: YouTube / Audio / Slides

Avac Event

HVTN Full Group Meeting

For more information, including the At-A-Glance and full program, click here.

Where:
Omni Shoreham Hotel
2500 Calvert Street NW
Washington, DC 20008

Avac Event

8th South African AIDS Conference

The South African AIDS Conference (SA AIDS) took place June 13-15 at the International Convention Centre in Durban. SA AIDS is an energizing, biennial conference that brings together a cross-section of the people and organizations sustaining the HIV/AIDS movement in South Africa.

This year’s theme, The Long Walk to Prevention: Every Voice Counts, comes at a critical time for HIV research and rollout in South Africa. In a time of both great uncertainty, but also of exciting dynamism in the prevention field, AVAC is thrilled to see the conference focusing on this essential component of a comprehensive AIDS response.

We gathered a full roadmap of prevention research oriented events and presentations. Download our roadmap here, and the full conference program here.

Key Sessions

  • Community Village — An interactive and participatory space to discuss cutting-edge issues in HIV, share knowledge and skills and network. Open to conference participants and to the general public.
  • Research Literacy Networking Zone — Wits RHI in partnership with AVAC, SAHTAC and APHA will disseminate research literacy materials and conduct fun and educational games focused on HIV prevention research R&D and advocacy. The zone will be located in the Women’s Networking Zone within the Community Village.
  • HIV Prevention and SRHR Masterclass
    Tuesday, June 13 – Thursday, June 15, 7:00 – 8:30 — Hosted by the African Alliance for HIV prevention at the Hilton Hotel.
  • Satellite Session: PrEP (sponsored by Gilead)
    Tuesday, June 13, 11:30 – 13:00 — Located in Hall 8b.
  • Up Your Game: Play to Learn About HIV Prevention and Research
    Tuesday, June 13, 12:00 – 13:00 — An HIV prevention research literacy game hosted on the main stage in the Community Village by AVAC, WRHI, SAHTAC and APHA.
  • Dapivirine Ring Licensure Program
    Tuesday, 13 June, 18:00 – 20:00 — This interactive satellite session, hosted by IPM, will showcase the developments in the dapivirine vaginal ring program. Located in Hall 5.
  • Basic Science: Putting the spanner in the works – the nuts and bolts of HIV prevention
    Wednesday, June 14, 9:00 – 11:00 — A roundtable plenary discussion with leading scientists. Located in Hall 1.
  • Improving HIV prevention by investing in research and development and services
    Wednesday, June 14, 11:30 – 13:00 — This workshop will provide health advocates and technical experts from the HIV prevention sector a platform to share ideas on how to improve implementation of R&D policies, and streamline regulatory processes that support the development, introduction and scale of high-impact health technologies in South Africa. Located in Hall 10.
  • Contraception and HIV: What they say, what we hear, what needs to change — a young women’s dialogue
    Wednesday, June 14, 18:00 – 20:00 — A roundtable dialogue with young advocates. Located in the Women’s Networking Zone.

AVAC posted live updates from the conference on our Facebook and Twitter pages. Blogs were posted on the WhatsUpHIV blog. The conference was on Twitter at @SAAIDS2017 and used the hashtag #SAAIDS2017.

Avac Event

Changing Faces, Changing Spaces

From the conference website:
Changing Faces, Changing Spaces is a Pan African Conference that brings together human rights activists and organizations, health and legal professionals, allies and donor partners from across Africa and beyond, undertaking and supporting African sex worker and LGBTIGNC activism. We deliberate, strategize and share the experiences that impact our movements. It is unique in the sense that it is a conference conceptualized and planned by a task force comprised by activists from the LGBTI and sex worker movements in Africa.

Click here for conference details.

Avac Event

Webinar: An Overview of Vaccine Development with Julie Ake of MHRP

Lieutenant Colonel Julie Ake, Principal Deputy Director of the US Military HIV Research Program (MHRP), wraps up our HVAD webinar series by providing an overview of MHRP’s HIV program and helping to connect dots in the HIV vaccine field.

Ake takes us through the landmark RV144 trial, the first HIV vaccine trial to show efficacy, and gives a clear and compelling update on where HIV vaccine research is and where it needs to go to ensure the development of a safe and effective vaccine. She also provides insight into the linkages to HIV treatment and cure research, as well as other vaccine development efforts, illuminating in particular the ways in which HIV vaccine research has informed Ebola and Zika vaccine development.

This was the fifth in our series of HIV Vaccine Awareness Day webinars. For details on the full series, visit avac.org/hvad.

Recording: YouTube / Audio / Slides

Avac Event

June 13, 2017

In this webinar, Jeff Taylor from the Care Collaboratory CAB at the University of North Carolina will discuss the basics needed to understand cure research and clinical trials, utilizing the CUREiculum, AVAC’s cure education tool.

Webinar objectives:

  • Define terms needed to understand cure research
  • Explore the major challenges to developing a cure
  • Understand the current state of cure research

Register at http://bit.ly/cure101

Avac Event

IAS 2017

The IAS 2017 conference took place between July 23–26 in Paris. Read on for details on AVAC satellite sessions, data to watch for and a prevention roadmap

Held every two years, this year’s conference included results from several HIV prevention trials, including data from HPTN’s Phase II long-acting injectable PrEP trial as well as Janssen’s Phase II vaccine trial, important findings from PrEP clinical trials, initial evidence of impact on confronting the epidemic in Swaziland, and more!

The full conference schedule is available on the conference website, and AVAC has pulled together an HIV prevention roadmap, sortable by timing, intervention and session type (also available as a PDF). The conference organizers have also engaged with partners to create additional roadmaps, which viewable here.

Following on the Web

  • In addition to AVAC’s online commentary on Twitter and Facebook, you could follow the official conference hashtag—#IAS2017.
  • Aidsmap was the official scientific news reporter for IAS 2017 and regularly updated its IAS 2017 page. Check it out here.
  • FHI 360 was an official media sponsor and hosted a digital live coverage hub for IAS 2017 on its Crowd 360 platform.
  • IAS Live debuted this year with IAS 2017 offering access to live streaming of the opening and closing sessions as well as the plenary sessions and press conferences. All session content is available through the online programme.

Satellite Sessions

Here are details on two satellite sessions that AVAC and partners are organized:

The Next Wave of Prevention Options: An update and interactive discussion on the pipeline of injections, infusions and implants—who will use, who will deliver, who will pay
Sunday, 23 July — Maillot Room
(Download flyer)

Advocates, researchers and implementers, including Ambassador Deborah Birx, discussed HIV prevention R&D—what potential users want from the next wave of prevention options, what’s scientifically feasible, what trials might look like, the development pathways and how to work together to accelerate progress.

Future Perfect: Opportunities and Obstacles for HIV Vaccines
Sunday, 23 July — Maillot Room
(Download flyer)

This satellite featured three state-of-the-art presentations on the vaccine pipeline, including passive immunization, promising vector-platforms, and the development of envelope proteins able to elicit broadly neutralizing antibodies.

Avac Event

Webinar: We’re On Our Way: Moving forward on the rectal road – new drugs, formulations and modes of delivery

This IRMA/AVAC teleconference featured Dr. Jose Bauermeister (University of Pennsylvania), Dr. Craig Hendrix (Johns Hopkins) and Dr. Kenneth Palmer (University of Louisville) who presented their promising new rectal microbicide research that is underway — we have new molecules, new formulations, new platforms for delivery and new acceptability explorations. Very exciting stuff!

On August 7, we glanced back at where we have been on this long and winding rectal road. On August 21, we looked to where we are going – where we need to go. It is this momentum we want to sustain. And it is the promise of a safe, effective, acceptable/desirable and accessible rectal microbicide for which we must fight — the future is not promised.

Recording: YouTube / Audio / Slides

Avac Event

Women Now 2016

Women Now! 2016 will provide an opportunity to assess the content and execution of the International AIDS Conference 2016. The Pan African Women’s Summit will provide an opportunity to assess the content and execution of the IAC for its meaningful inclusion of women’s and girls’ sexual & reproductive health and justice, especially women and girls of African descent, who bear the brunt of the HIV pandemic among women worldwide.

The summit will address critical areas of concern for women’s human rights, through an intersectional lens, including key issues of race, economic status, gender equality, women’s empowerment, gender-based trauma and violence, and sexual and reproductive health, rights and justice.